A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis
- PMID: 34038382
- DOI: 10.1212/WNL.0000000000011862
A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis
Comment on
-
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.Neurology. 2021 May 4;96(18):e2313-e2322. doi: 10.1212/WNL.0000000000011863. Epub 2021 Mar 23. Neurology. 2021. PMID: 34038379 Clinical Trial.
Similar articles
-
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.Neurology. 2021 May 4;96(18):e2313-e2322. doi: 10.1212/WNL.0000000000011863. Epub 2021 Mar 23. Neurology. 2021. PMID: 34038379 Clinical Trial.
-
Occasional essay: Multiple sclerosis in the digital age: 'seeing through a glass darkly'.J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1017-1023. doi: 10.1136/jnnp-2020-323235. Epub 2020 Jul 24. J Neurol Neurosurg Psychiatry. 2020. PMID: 32709701 No abstract available.
-
New Drug For Multiple Sclerosis.Am J Nurs. 2017 Jul;117(7):22. doi: 10.1097/01.NAJ.0000520941.01106.1b. Am J Nurs. 2017. PMID: 28644283 No abstract available.
-
Ocrelizumab for the treatment of multiple sclerosis.Expert Rev Neurother. 2019 Feb;19(2):97-108. doi: 10.1080/14737175.2019.1561284. Epub 2018 Dec 28. Expert Rev Neurother. 2019. PMID: 30570368 Review.
-
Current disease-modifying therapies in multiple sclerosis.Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138. Semin Neurol. 2003. PMID: 12894379 Review.
Cited by
-
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.Mult Scler. 2022 Jan;28(1):16-28. doi: 10.1177/13524585211059766. Epub 2021 Dec 1. Mult Scler. 2022. PMID: 34850641 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical